Can Non-Statin Cholesterol Meds Help Your Liver?
By Ernie Mundell HealthDay Reporter
WEDNESDAY, July 31, 2024 -- Prior studies have found that statin meds can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same.
A team led by Katherine McGlynn of the U.S. National Cancer Institute looked at the health histories of almost 19,000 people tracked by the U.K.'s Clinical Practice Research Datalink.
About 3,700 of them developed liver cancer, and their medication use was compared to almost 15,000 others who did not get the disease.
McGlynn's team linked use of a non-statin form of cholesterol-lowering meds, called cholesterol absorption inhibitors, to 31% lower odds of developing liver cancer. Their findings were reported July 29 in the journal Cancer.
The link held when the researchers accounted for other risk factors such as diabetes and liver disease status.
The study also re-confirmed that statins lower liver cancer risk by 35%.
But the use of three other medicines used to lower cholesterol -- fibrates, omega-3 fatty acids and niacin -- did not seem to affect liver cancer risk, the research showed. Risks attributed to another drug type, bile acid sequestrants, were inconclusive.
“As few studies have examined the effects of non-statin cholesterol-lowering drugs on liver cancer risk, the results of our study require replication in other populations," McGlynn said in a journal news release. "If our findings are confirmed in other studies, however, our results may inform liver cancer prevention research."
Sources
- Wiley journals, news release, July 29, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Common Meds Appear To Delay Onset Of Parkinson's Disease
THURSDAY, April 17, 2025 -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study...
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
TUESDAY, April 15, 2025 -- The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or...
Low 'Bad' Cholesterol Might Protect Against Dementia, Alzheimer's
WEDNESDAY, April 2, 2025 -- Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.